ANIP - ANI Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$124.00
DETAILS
HIGH:
$124.00
LOW:
$124.00
MEDIAN:
$124.00
CONSENSUS:
$124.00
UPSIDE:
49.90%
About ANI Pharmaceuticals, Inc. (https://www.anipharmaceuticals.com)
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Nikhil Lalwani | President, Chief Executive Officer & Director | 1978 | $2,429,909 USD |
| Christopher K. Mutz | Senior Vice President & Head of Rare Disease | 1972 | $1,266,375 USD |
| Stephen Carey | Senior Vice President of Finance & Chief Financial Officer | 1971 | $1,121,543 USD |
| Ori Gutwerg | Senior Vice President of Generics | 1975 | $964,148 USD |
| Meredith W. Cook | Senior Vice President, General Counsel & Corporate Secretary | 1974 | $860,808 USD |
| Chad Gassert | Senior Vice President of Corporate Development & Strategy | 1976 | $849,711 USD |
| Elizabeth Powell | Chief Compliance Officer & Head of Legal of Rare Disease | – | – |
| Krista L. Davis | Senior Vice President & Chief Human Resources Officer | 1973 | – |
| Mary Pao | Chief Medical Officer | – | – |
| Muthusamy Shanmugam | Head of R&D, Chief Operating Officer of New Jersey Operations & Director | 1968 | – |
| Thomas Andrew Rowland | Senior Vice President & Head of Established Brands | 1967 | – |